Unresolved disorder model. using A ATOM 227 CA AGLU 31 18.802 -36.453 -0.580 0.50 22.90 C Unresolved disorder model. using A ATOM 228 CA BGLU 31 18.789 -36.442 -0.588 0.50 24.31 C Unresolved disorder model. using A ATOM 231 CB AGLU 31 18.398 -37.020 0.821 0.50 21.95 C Unresolved disorder model. using A ATOM 232 CB BGLU 31 18.273 -37.018 0.736 0.50 24.88 C Unresolved disorder model. using A ATOM 233 CG AGLU 31 17.196 -38.029 0.859 0.50 22.99 C Unresolved disorder model. using A ATOM 234 CG BGLU 31 18.138 -36.005 1.893 0.50 30.02 C Unresolved disorder model. using A ATOM 235 CD AGLU 31 16.945 -38.814 2.237 0.50 25.54 C Unresolved disorder model. using A ATOM 236 CD BGLU 31 19.457 -35.351 2.244 0.50 32.62 C Unresolved disorder model. using A ATOM 237 OE1AGLU 31 17.275 -38.391 3.353 0.50 19.19 O Unresolved disorder model. using A ATOM 238 OE1BGLU 31 20.469 -36.011 1.980 0.50 33.34 O Unresolved disorder model. using A ATOM 239 OE2AGLU 31 16.324 -39.886 2.199 0.50 28.41 O Unresolved disorder model. using A ATOM 240 OE2BGLU 31 19.497 -34.188 2.742 0.50 30.99 O Unresolved disorder model. using A ATOM 268 N AGLU 36 14.737 -46.337 -3.060 0.50 27.69 N Unresolved disorder model. using A ATOM 269 N BGLU 36 14.662 -46.468 -3.015 0.50 30.79 N Unresolved disorder model. using A ATOM 270 CA AGLU 36 13.584 -45.811 -2.371 0.50 29.10 C Unresolved disorder model. using A ATOM 271 CA BGLU 36 13.465 -45.780 -2.447 0.50 32.92 C Unresolved disorder model. using A ATOM 272 C AGLU 36 13.001 -46.976 -1.617 0.50 27.50 C Unresolved disorder model. using A ATOM 273 C BGLU 36 12.498 -46.570 -1.527 0.50 31.42 C Unresolved disorder model. using A ATOM 274 O AGLU 36 12.739 -48.026 -2.231 0.50 26.20 O Unresolved disorder model. using A ATOM 275 O BGLU 36 11.378 -46.894 -1.903 0.50 29.04 O Unresolved disorder model. using A ATOM 276 CB AGLU 36 12.566 -45.207 -3.312 0.50 27.37 C Unresolved disorder model. using A ATOM 277 CB BGLU 36 12.657 -45.076 -3.537 0.50 32.95 C Unresolved disorder model. using A ATOM 278 CG AGLU 36 11.528 -44.362 -2.530 0.50 27.40 C Unresolved disorder model. using A ATOM 279 CG BGLU 36 11.764 -43.986 -2.924 0.50 41.26 C Unresolved disorder model. using A ATOM 280 CD AGLU 36 10.557 -43.603 -3.468 0.50 33.74 C Unresolved disorder model. using A ATOM 281 CD BGLU 36 10.664 -43.473 -3.856 0.50 45.36 C Unresolved disorder model. using A ATOM 282 OE1AGLU 36 10.072 -44.225 -4.439 0.50 30.41 O Unresolved disorder model. using A ATOM 283 OE1BGLU 36 10.504 -44.034 -4.955 0.50 44.50 O Unresolved disorder model. using A ATOM 284 OE2AGLU 36 10.239 -42.402 -3.229 0.50 28.74 O Unresolved disorder model. using A ATOM 285 OE2BGLU 36 9.949 -42.504 -3.486 0.50 44.51 O Unresolved disorder model. using A ATOM 367 CA ALYS 47 13.336 -34.254 8.496 0.50 18.49 C Unresolved disorder model. using A ATOM 368 CA BLYS 47 13.330 -34.244 8.537 0.50 18.91 C Unresolved disorder model. using A ATOM 371 CB ALYS 47 14.500 -34.622 7.568 0.50 17.53 C Unresolved disorder model. using A ATOM 372 CB BLYS 47 14.620 -34.598 7.762 0.50 19.79 C Unresolved disorder model. using A ATOM 373 CG ALYS 47 15.370 -35.755 8.106 0.50 22.08 C Unresolved disorder model. using A ATOM 374 CG BLYS 47 15.694 -35.326 8.648 0.50 22.49 C Unresolved disorder model. using A ATOM 375 CD ALYS 47 16.642 -35.922 7.252 0.50 19.59 C Unresolved disorder model. using A ATOM 376 CD BLYS 47 16.982 -35.802 7.839 0.50 24.39 C Unresolved disorder model. using A ATOM 377 CE ALYS 47 16.431 -36.724 6.013 0.50 18.73 C Unresolved disorder model. using A ATOM 378 CE BLYS 47 17.897 -34.649 7.443 0.50 28.33 C Unresolved disorder model. using A ATOM 379 NZ ALYS 47 17.762 -36.705 5.317 0.50 21.13 N Unresolved disorder model. using A ATOM 380 NZ BLYS 47 19.207 -34.913 6.682 0.50 33.16 N Unresolved disorder model. using A ATOM 446 N ATHR 56 0.504 -31.004 3.905 0.50 22.14 N Unresolved disorder model. using A ATOM 447 N BTHR 56 0.405 -31.024 3.890 0.50 24.50 N Unresolved disorder model. using A ATOM 448 CA ATHR 56 0.018 -31.969 2.942 0.50 25.14 C Unresolved disorder model. using A ATOM 449 CA BTHR 56 -0.010 -32.175 3.116 0.50 28.44 C Unresolved disorder model. using A ATOM 450 C ATHR 56 1.153 -32.487 2.066 0.50 25.12 C Unresolved disorder model. using A ATOM 451 C BTHR 56 1.168 -32.526 2.234 0.50 27.10 C Unresolved disorder model. using A ATOM 452 O ATHR 56 1.832 -31.698 1.422 0.50 25.96 O Unresolved disorder model. using A ATOM 453 O BTHR 56 1.914 -31.670 1.813 0.50 28.30 O Unresolved disorder model. using A ATOM 454 CB ATHR 56 -1.007 -31.292 2.043 0.50 22.58 C Unresolved disorder model. using A ATOM 455 CB BTHR 56 -1.264 -31.856 2.285 0.50 32.61 C Unresolved disorder model. using A ATOM 456 OG1ATHR 56 -2.211 -31.107 2.810 0.50 20.82 O Unresolved disorder model. using A ATOM 457 OG1BTHR 56 -1.480 -32.852 1.261 0.50 33.18 O Unresolved disorder model. using A ATOM 458 CG2ATHR 56 -1.325 -32.169 0.836 0.50 25.06 C Unresolved disorder model. using A ATOM 459 CG2BTHR 56 -1.092 -30.532 1.652 0.50 28.75 C Unresolved disorder model. using A ATOM 461 CA AVAL 57 2.332 -34.280 1.004 0.50 24.95 C Unresolved disorder model. using A ATOM 462 CA BVAL 57 2.332 -34.281 1.013 0.50 23.84 C Unresolved disorder model. using A ATOM 465 CB AVAL 57 3.461 -35.074 1.687 0.50 24.04 C Unresolved disorder model. using A ATOM 466 CB BVAL 57 3.380 -35.129 1.734 0.50 20.77 C Unresolved disorder model. using A ATOM 467 CG1AVAL 57 2.947 -36.331 2.264 0.50 28.51 C Unresolved disorder model. using A ATOM 468 CG1BVAL 57 4.197 -36.032 0.749 0.50 26.12 C Unresolved disorder model. using A ATOM 469 CG2AVAL 57 4.668 -35.367 0.709 0.50 26.33 C Unresolved disorder model. using A ATOM 470 CG2BVAL 57 4.329 -34.194 2.532 0.50 19.56 C Unresolved disorder model. using A ATOM 482 CA ATHR 59 3.363 -38.989 -2.433 0.50 20.80 C Unresolved disorder model. using A ATOM 483 CA BTHR 59 3.372 -38.956 -2.416 0.50 24.60 C Unresolved disorder model. using A ATOM 486 CB ATHR 59 2.953 -40.314 -1.732 0.50 22.36 C Unresolved disorder model. using A ATOM 487 CB BTHR 59 2.961 -40.176 -1.558 0.50 32.62 C Unresolved disorder model. using A ATOM 488 OG1ATHR 59 1.658 -40.720 -2.202 0.50 18.03 O Unresolved disorder model. using A ATOM 489 OG1BTHR 59 2.207 -39.713 -0.417 0.50 35.64 O Unresolved disorder model. using A ATOM 490 CG2ATHR 59 2.995 -40.177 -0.119 0.50 21.44 C Unresolved disorder model. using A ATOM 491 CG2BTHR 59 4.187 -40.942 -1.053 0.50 32.88 C Unresolved disorder model. using A ATOM 558 CA ATHR 69 6.205 -46.712 7.829 0.50 23.12 C Unresolved disorder model. using A ATOM 559 CA BTHR 69 6.244 -46.699 7.832 0.50 28.38 C Unresolved disorder model. using A ATOM 562 CB ATHR 69 7.527 -47.224 7.452 0.50 21.94 C Unresolved disorder model. using A ATOM 563 CB BTHR 69 7.744 -47.092 7.566 0.50 35.27 C Unresolved disorder model. using A ATOM 564 OG1ATHR 69 7.534 -48.642 7.691 0.50 21.78 O Unresolved disorder model. using A ATOM 565 OG1BTHR 69 7.970 -47.306 6.163 0.50 51.24 O Unresolved disorder model. using A ATOM 566 CG2ATHR 69 8.667 -46.490 8.169 0.50 16.84 C Unresolved disorder model. using A ATOM 567 CG2BTHR 69 8.181 -48.350 8.351 0.50 38.59 C Unresolved disorder model. using A ATOM 646 CA ALYS 80 -1.946 -35.312 5.522 0.50 29.56 C Unresolved disorder model. using A ATOM 647 CA BLYS 80 -1.946 -35.249 5.494 0.50 28.29 C Unresolved disorder model. using A ATOM 650 CB ALYS 80 -3.130 -34.446 5.075 0.50 35.49 C Unresolved disorder model. using A ATOM 651 CB BLYS 80 -2.926 -34.200 4.983 0.50 27.38 C Unresolved disorder model. using A ATOM 652 CG ALYS 80 -4.200 -35.223 4.246 0.50 30.91 C Unresolved disorder model. using A ATOM 653 CG BLYS 80 -3.822 -33.642 6.072 0.50 26.81 C Unresolved disorder model. using A ATOM 654 CD ALYS 80 -5.410 -34.337 3.998 0.50 44.64 C Unresolved disorder model. using A ATOM 655 CD BLYS 80 -4.991 -32.948 5.361 0.50 35.88 C Unresolved disorder model. using A ATOM 656 CE ALYS 80 -6.123 -34.733 2.697 0.50 49.42 C Unresolved disorder model. using A ATOM 657 CE BLYS 80 -5.771 -32.163 6.346 0.50 42.49 C Unresolved disorder model. using A ATOM 658 NZ ALYS 80 -7.576 -34.850 2.940 0.50 54.72 N Unresolved disorder model. using A ATOM 659 NZ BLYS 80 -6.151 -30.944 5.668 0.50 37.23 N Unresolved disorder model. using A ATOM 691 CA AILE 85 -2.170 -38.346 -9.144 0.50 46.76 C Unresolved disorder model. using A ATOM 692 CA BILE 85 -2.071 -38.327 -9.174 0.50 50.88 C Unresolved disorder model. using A ATOM 695 CB AILE 85 -3.564 -39.055 -9.011 0.50 47.36 C Unresolved disorder model. using A ATOM 696 CB BILE 85 -3.275 -39.305 -9.288 0.50 57.20 C Unresolved disorder model. using A ATOM 697 CG1AILE 85 -3.413 -40.525 -8.542 0.50 37.02 C Unresolved disorder model. using A ATOM 698 CG1BILE 85 -3.980 -39.140 -10.634 0.50 57.23 C Unresolved disorder model. using A ATOM 699 CG2AILE 85 -4.355 -38.986 -10.336 0.50 51.83 C Unresolved disorder model. using A ATOM 700 CG2BILE 85 -4.272 -39.119 -8.196 0.50 60.26 C Unresolved disorder model. using A ATOM 701 CD1AILE 85 -4.727 -41.223 -7.947 0.50 29.33 C Unresolved disorder model. using A ATOM 702 CD1BILE 85 -3.095 -39.444 -11.761 0.50 49.02 C Unresolved disorder model. using A ATOM 722 N AASN 88 -4.493 -32.446 -12.387 0.50 73.14 N Unresolved disorder model. using A ATOM 723 N BASN 88 -4.466 -32.482 -12.382 0.50 75.12 N Unresolved disorder model. using A ATOM 724 CA AASN 88 -4.111 -31.458 -13.390 0.50 73.06 C Unresolved disorder model. using A ATOM 725 CA BASN 88 -4.019 -31.461 -13.316 0.50 77.08 C Unresolved disorder model. using A ATOM 726 C AASN 88 -2.978 -32.074 -14.218 0.50 84.66 C Unresolved disorder model. using A ATOM 727 C BASN 88 -2.940 -32.110 -14.210 0.50 86.05 C Unresolved disorder model. using A ATOM 728 O AASN 88 -1.907 -32.373 -13.677 0.50 80.48 O Unresolved disorder model. using A ATOM 729 O BASN 88 -1.870 -32.471 -13.706 0.50 79.10 O Unresolved disorder model. using A ATOM 730 CB AASN 88 -3.690 -30.118 -12.774 0.50 63.06 C Unresolved disorder model. using A ATOM 731 CB BASN 88 -3.459 -30.263 -12.535 0.50 68.89 C Unresolved disorder model. using A ATOM 732 CG AASN 88 -3.475 -29.047 -13.826 0.50 56.92 C Unresolved disorder model. using A ATOM 733 CG BASN 88 -2.779 -30.681 -11.228 0.50 68.86 C Unresolved disorder model. using A ATOM 734 OD1AASN 88 -2.697 -29.222 -14.758 0.50 46.80 O Unresolved disorder model. using A ATOM 735 OD1BASN 88 -2.806 -31.859 -10.835 0.50 64.70 O Unresolved disorder model. using A ATOM 736 ND2AASN 88 -4.192 -27.940 -13.692 0.50 58.39 N Unresolved disorder model. using A ATOM 737 ND2BASN 88 -2.166 -29.720 -10.553 0.50 57.88 N Unresolved disorder model. using A ATOM 910 N AASP 111 31.963 -32.426 -11.272 0.50 38.17 N Unresolved disorder model. using A ATOM 911 N BASP 111 32.041 -32.497 -11.245 0.50 40.60 N Unresolved disorder model. using A ATOM 912 CA AASP 111 33.435 -32.407 -11.133 0.50 42.72 C Unresolved disorder model. using A ATOM 913 CA BASP 111 33.508 -32.675 -10.993 0.50 42.38 C Unresolved disorder model. using A ATOM 914 C AASP 111 33.952 -32.038 -9.734 0.50 42.46 C Unresolved disorder model. using A ATOM 915 C BASP 111 34.089 -31.803 -9.839 0.50 44.71 C Unresolved disorder model. using A ATOM 916 O AASP 111 34.962 -32.571 -9.248 0.50 36.52 O Unresolved disorder model. using A ATOM 917 O BASP 111 35.316 -31.716 -9.634 0.50 38.90 O Unresolved disorder model. using A ATOM 918 CB AASP 111 34.065 -31.478 -12.209 0.50 42.16 C Unresolved disorder model. using A ATOM 919 CB BASP 111 34.338 -32.459 -12.279 0.50 49.60 C Unresolved disorder model. using A ATOM 920 CG AASP 111 33.757 -29.985 -12.010 0.50 46.82 C Unresolved disorder model. using A ATOM 921 CG BASP 111 33.885 -33.351 -13.447 0.50 50.81 C Unresolved disorder model. using A ATOM 922 OD1AASP 111 34.721 -29.210 -11.786 0.50 46.38 O Unresolved disorder model. using A ATOM 923 OD1BASP 111 34.697 -34.208 -13.896 0.50 59.73 O Unresolved disorder model. using A ATOM 924 OD2AASP 111 32.578 -29.554 -12.098 0.50 45.97 O Unresolved disorder model. using A ATOM 925 OD2BASP 111 32.728 -33.187 -13.923 0.50 48.73 O Unresolved disorder model. using A ATOM 1380 N AVAL 170 22.263 -23.589 15.042 0.50 25.86 N Unresolved disorder model. using A ATOM 1381 N BVAL 170 22.239 -23.611 15.069 0.50 25.82 N Unresolved disorder model. using A ATOM 1382 CA AVAL 170 21.157 -22.775 15.624 0.50 23.18 C Unresolved disorder model. using A ATOM 1383 CA BVAL 170 21.073 -22.863 15.591 0.50 22.11 C Unresolved disorder model. using A ATOM 1384 C AVAL 170 21.109 -21.445 14.915 0.50 23.06 C Unresolved disorder model. using A ATOM 1385 C BVAL 170 21.077 -21.462 14.993 0.50 22.66 C Unresolved disorder model. using A ATOM 1386 O AVAL 170 22.154 -20.797 14.710 0.50 24.12 O Unresolved disorder model. using A ATOM 1387 O BVAL 170 22.130 -20.803 14.899 0.50 23.90 O Unresolved disorder model. using A ATOM 1388 CB AVAL 170 21.420 -22.468 17.097 0.50 28.47 C Unresolved disorder model. using A ATOM 1389 CB BVAL 170 21.066 -22.830 17.117 0.50 27.92 C Unresolved disorder model. using A ATOM 1390 CG1AVAL 170 20.225 -21.717 17.717 0.50 27.04 C Unresolved disorder model. using A ATOM 1391 CG1BVAL 170 22.354 -22.212 17.636 0.50 21.93 C Unresolved disorder model. using A ATOM 1392 CG2AVAL 170 21.681 -23.743 17.830 0.50 25.22 C Unresolved disorder model. using A ATOM 1393 CG2BVAL 170 19.837 -22.070 17.618 0.50 24.94 C Unresolved disorder model. using A ATOM 1461 CA AGLU 180 22.177 -34.504 12.289 0.50 23.14 C Unresolved disorder model. using A ATOM 1462 CA BGLU 180 22.171 -34.497 12.298 0.50 25.43 C Unresolved disorder model. using A ATOM 1465 CB AGLU 180 22.875 -34.389 10.909 0.50 22.02 C Unresolved disorder model. using A ATOM 1466 CB BGLU 180 22.945 -34.326 10.998 0.50 26.58 C Unresolved disorder model. using A ATOM 1467 CG AGLU 180 24.408 -33.955 10.892 0.50 22.68 C Unresolved disorder model. using A ATOM 1468 CG BGLU 180 22.179 -33.734 9.813 0.50 35.84 C Unresolved disorder model. using A ATOM 1469 CD AGLU 180 25.188 -34.120 9.492 0.50 27.60 C Unresolved disorder model. using A ATOM 1470 CD BGLU 180 20.963 -34.528 9.456 0.50 37.77 C Unresolved disorder model. using A ATOM 1471 OE1AGLU 180 24.617 -34.199 8.398 0.50 20.18 O Unresolved disorder model. using A ATOM 1472 OE1BGLU 180 20.933 -35.719 9.828 0.50 38.27 O Unresolved disorder model. using A ATOM 1473 OE2AGLU 180 26.441 -34.104 9.485 0.50 28.55 O Unresolved disorder model. using A ATOM 1474 OE2BGLU 180 20.038 -33.982 8.815 0.50 36.32 O Unresolved disorder model. using A ATOM 1502 N AGLU 185 32.740 -35.900 14.742 0.50 26.04 N Unresolved disorder model. using A ATOM 1503 N BGLU 185 32.896 -35.914 14.716 0.50 29.50 N Unresolved disorder model. using A ATOM 1504 CA AGLU 185 32.838 -34.650 13.997 0.50 27.21 C Unresolved disorder model. using A ATOM 1505 CA BGLU 185 32.915 -34.511 14.161 0.50 32.19 C Unresolved disorder model. using A ATOM 1506 C AGLU 185 34.187 -34.698 13.321 0.50 26.43 C Unresolved disorder model. using A ATOM 1507 C BGLU 185 34.109 -34.097 13.234 0.50 30.81 C Unresolved disorder model. using A ATOM 1508 O AGLU 185 35.219 -34.930 13.986 0.50 29.19 O Unresolved disorder model. using A ATOM 1509 O BGLU 185 34.963 -33.297 13.618 0.50 35.63 O Unresolved disorder model. using A ATOM 1510 CB AGLU 185 32.719 -33.441 14.903 0.50 23.83 C Unresolved disorder model. using A ATOM 1511 CB BGLU 185 32.793 -33.509 15.329 0.50 30.53 C Unresolved disorder model. using A ATOM 1512 CG AGLU 185 32.621 -32.116 14.143 0.50 23.31 C Unresolved disorder model. using A ATOM 1513 CG BGLU 185 32.164 -32.187 14.923 0.50 37.62 C Unresolved disorder model. using A ATOM 1514 CD AGLU 185 32.511 -30.943 15.130 0.50 27.33 C Unresolved disorder model. using A ATOM 1515 CD BGLU 185 32.429 -31.045 15.907 0.50 40.77 C Unresolved disorder model. using A ATOM 1516 OE1AGLU 185 33.375 -30.879 16.043 0.50 26.18 O Unresolved disorder model. using A ATOM 1517 OE1BGLU 185 32.897 -31.303 17.030 0.50 40.18 O Unresolved disorder model. using A ATOM 1518 OE2AGLU 185 31.592 -30.081 14.999 0.50 21.53 O Unresolved disorder model. using A ATOM 1519 OE2BGLU 185 32.156 -29.869 15.559 0.50 43.93 O Unresolved disorder model. using A ATOM 1601 CA ALYS 196 22.981 -28.687 3.234 0.50 17.78 C Unresolved disorder model. using A ATOM 1602 CA BLYS 196 22.980 -28.664 3.173 0.50 18.81 C Unresolved disorder model. using A ATOM 1605 CB ALYS 196 22.747 -29.892 4.172 0.50 14.80 C Unresolved disorder model. using A ATOM 1606 CB BLYS 196 22.669 -29.976 3.922 0.50 18.67 C Unresolved disorder model. using A ATOM 1607 CG ALYS 196 23.299 -31.185 3.593 0.50 16.88 C Unresolved disorder model. using A ATOM 1608 CG BLYS 196 22.925 -31.210 3.035 0.50 21.67 C Unresolved disorder model. using A ATOM 1609 CD ALYS 196 22.845 -32.398 4.414 0.50 14.86 C Unresolved disorder model. using A ATOM 1610 CD BLYS 196 22.592 -32.559 3.768 0.50 23.22 C Unresolved disorder model. using A ATOM 1611 CE ALYS 196 23.517 -32.480 5.720 0.50 16.88 C Unresolved disorder model. using A ATOM 1612 CE BLYS 196 21.118 -32.768 3.913 0.50 27.54 C Unresolved disorder model. using A ATOM 1613 NZ ALYS 196 22.973 -33.723 6.387 0.50 19.01 N Unresolved disorder model. using A ATOM 1614 NZ BLYS 196 20.721 -33.854 4.877 0.50 38.29 N Unresolved disorder model. using A ATOM 1688 CA AVAL 206 28.536 -19.200 10.750 0.50 23.91 C Unresolved disorder model. using A ATOM 1689 CA BVAL 206 28.497 -19.167 10.791 0.50 24.41 C Unresolved disorder model. using A ATOM 1692 CB AVAL 206 28.799 -20.494 9.959 0.50 20.40 C Unresolved disorder model. using A ATOM 1693 CB BVAL 206 28.606 -20.550 10.101 0.50 22.33 C Unresolved disorder model. using A ATOM 1694 CG1AVAL 206 29.285 -21.642 10.852 0.50 24.48 C Unresolved disorder model. using A ATOM 1695 CG1BVAL 206 29.918 -20.702 9.427 0.50 24.21 C Unresolved disorder model. using A ATOM 1696 CG2AVAL 206 27.502 -20.886 9.195 0.50 19.00 C Unresolved disorder model. using A ATOM 1697 CG2BVAL 206 28.327 -21.725 11.100 0.50 21.86 C Unresolved disorder model. using A ATOM 1709 CA ATHR 208 32.041 -22.388 14.174 0.50 21.60 C Unresolved disorder model. using A ATOM 1710 CA BTHR 208 32.045 -22.357 14.153 0.50 24.38 C Unresolved disorder model. using A ATOM 1713 CB ATHR 208 33.389 -22.715 13.480 0.50 21.46 C Unresolved disorder model. using A ATOM 1714 CB BTHR 208 33.334 -22.470 13.340 0.50 30.06 C Unresolved disorder model. using A ATOM 1715 OG1ATHR 208 34.396 -21.811 13.942 0.50 17.90 O Unresolved disorder model. using A ATOM 1716 OG1BTHR 208 33.182 -21.655 12.150 0.50 32.92 O Unresolved disorder model. using A ATOM 1717 CG2ATHR 208 33.285 -22.679 11.882 0.50 24.02 C Unresolved disorder model. using A ATOM 1718 CG2BTHR 208 33.627 -23.893 12.927 0.50 29.09 C Unresolved disorder model. using A ATOM 1785 CA ATHR 218 37.350 -28.747 3.891 0.50 24.49 C Unresolved disorder model. using A ATOM 1786 CA BTHR 218 37.305 -28.790 3.907 0.50 28.84 C Unresolved disorder model. using A ATOM 1789 CB ATHR 218 37.129 -30.152 4.231 0.50 24.25 C Unresolved disorder model. using A ATOM 1790 CB BTHR 218 36.819 -30.239 4.260 0.50 33.84 C Unresolved disorder model. using A ATOM 1791 OG1ATHR 218 38.361 -30.834 3.958 0.50 21.26 O Unresolved disorder model. using A ATOM 1792 OG1BTHR 218 36.961 -30.484 5.671 0.50 47.40 O Unresolved disorder model. using A ATOM 1793 CG2ATHR 218 35.999 -30.756 3.453 0.50 18.95 C Unresolved disorder model. using A ATOM 1794 CG2BTHR 218 37.565 -31.338 3.456 0.50 35.41 C Unresolved disorder model. using A ATOM 1873 CA ALYS 229 31.486 -15.943 6.251 0.50 27.58 C Unresolved disorder model. using A ATOM 1874 CA BLYS 229 31.525 -15.950 6.230 0.50 28.23 C Unresolved disorder model. using A ATOM 1877 CB ALYS 229 31.092 -14.570 6.790 0.50 28.24 C Unresolved disorder model. using A ATOM 1878 CB BLYS 229 31.321 -14.491 6.709 0.50 32.74 C Unresolved disorder model. using A ATOM 1879 CG ALYS 229 30.930 -13.581 5.708 0.50 25.31 C Unresolved disorder model. using A ATOM 1880 CG BLYS 229 32.586 -13.876 7.402 0.50 28.51 C Unresolved disorder model. using A ATOM 1881 CD ALYS 229 30.924 -12.180 6.308 0.50 31.98 C Unresolved disorder model. using A ATOM 1882 CD BLYS 229 32.510 -12.338 7.478 0.50 36.27 C Unresolved disorder model. using A ATOM 1883 CE ALYS 229 29.973 -11.385 5.489 0.50 37.48 C Unresolved disorder model. using A ATOM 1884 CE BLYS 229 33.899 -11.641 7.632 0.50 32.09 C Unresolved disorder model. using A ATOM 1885 NZ ALYS 229 29.825 -10.109 6.178 0.50 39.59 N Unresolved disorder model. using A ATOM 1886 NZ BLYS 229 35.003 -12.476 8.203 0.50 40.88 N Unresolved disorder model. using A ATOM 2034 CA ALYS 249 20.331 -30.046 27.892 0.50 40.33 C Unresolved disorder model. using A ATOM 2035 CA BLYS 249 20.334 -30.055 27.891 0.50 41.52 C Unresolved disorder model. using A ATOM 2038 CB ALYS 249 20.405 -29.263 29.225 0.50 43.19 C Unresolved disorder model. using A ATOM 2039 CB BLYS 249 20.392 -29.299 29.242 0.50 47.05 C Unresolved disorder model. using A ATOM 2040 CG ALYS 249 19.535 -29.813 30.354 0.50 40.82 C Unresolved disorder model. using A ATOM 2041 CG BLYS 249 21.691 -29.454 30.056 0.50 47.88 C Unresolved disorder model. using A ATOM 2042 CD ALYS 249 19.897 -29.195 31.707 0.50 37.63 C Unresolved disorder model. using A ATOM 2043 CD BLYS 249 21.516 -28.850 31.472 0.50 45.97 C Unresolved disorder model. using A ATOM 2044 CE ALYS 249 18.940 -29.742 32.773 0.50 43.18 C Unresolved disorder model. using A ATOM 2045 CE BLYS 249 22.878 -28.678 32.146 0.50 55.52 C Unresolved disorder model. using A ATOM 2046 NZ ALYS 249 19.338 -29.332 34.157 0.50 54.17 N Unresolved disorder model. using A ATOM 2047 NZ BLYS 249 22.754 -28.224 33.578 0.50 61.28 N Unresolved disorder model. using A ATOM 2057 N ALEU 251 17.671 -30.259 24.276 0.50 32.22 N Unresolved disorder model. using A ATOM 2058 N BLEU 251 17.672 -30.243 24.280 0.50 29.53 N Unresolved disorder model. using A ATOM 2059 CA ALEU 251 17.620 -31.255 23.194 0.50 28.68 C Unresolved disorder model. using A ATOM 2060 CA BLEU 251 17.614 -31.203 23.181 0.50 25.50 C Unresolved disorder model. using A ATOM 2061 C ALEU 251 17.679 -32.664 23.689 0.50 29.45 C Unresolved disorder model. using A ATOM 2062 C BLEU 251 17.708 -32.640 23.656 0.50 26.43 C Unresolved disorder model. using A ATOM 2063 O ALEU 251 16.879 -33.522 23.276 0.50 28.08 O Unresolved disorder model. using A ATOM 2064 O BLEU 251 16.928 -33.492 23.219 0.50 26.68 O Unresolved disorder model. using A ATOM 2065 CB ALEU 251 18.764 -31.032 22.205 0.50 30.94 C Unresolved disorder model. using A ATOM 2066 CB BLEU 251 18.700 -30.873 22.139 0.50 23.81 C Unresolved disorder model. using A ATOM 2067 CG ALEU 251 18.385 -29.948 21.236 0.50 29.41 C Unresolved disorder model. using A ATOM 2068 CG BLEU 251 18.699 -31.715 20.884 0.50 19.09 C Unresolved disorder model. using A ATOM 2069 CD1ALEU 251 19.530 -29.757 20.263 0.50 32.87 C Unresolved disorder model. using A ATOM 2070 CD1BLEU 251 17.405 -31.511 20.144 0.50 21.89 C Unresolved disorder model. using A ATOM 2071 CD2ALEU 251 17.059 -30.390 20.512 0.50 28.52 C Unresolved disorder model. using A ATOM 2072 CD2BLEU 251 19.836 -31.116 20.021 0.50 25.81 C 1